Bottom line
How much do XLV and PHSYX overlap?
67% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 70.0% of XLV's assets and 65.4% of PHSYX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and PHSYX have in common
| Holding | % of XLV | % of PHSYX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 13.15% | 13.15% |
| Johnson & Johnson | 10.64% | 8.46% | 8.46% |
| AbbVie Inc | 7.74% | 6.05% | 6.05% |
| UnitedHealth Group Inc | 6.57% | 6.93% | 6.57% |
| Merck & Co Inc | 5.52% | 4.88% | 4.88% |
| Amgen Inc | 3.40% | 1.11% | 1.11% |
| Thermo Fisher Scientific Inc | 3.24% | 4.50% | 3.24% |
| Gilead Sciences Inc | 2.73% | 2.63% | 2.63% |
| Intuitive Surgical Inc | 2.45% | 4.04% | 2.45% |
| CVS Health Corp | 2.30% | 2.74% | 2.30% |
| Vertex Pharmaceuticals Inc | 2.19% | 1.97% | 1.97% |
| Bristol-Myers Squibb Co | 2.05% | 1.75% | 1.75% |
| McKesson Corp | 1.58% | 2.14% | 1.58% |
| Boston Scientific Corp | 1.10% | 1.80% | 1.10% |
| HCA Healthcare Inc | 1.05% | 1.18% | 1.05% |
| Cardinal Health Inc | 0.97% | 2.12% | 0.97% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- Abbott Laboratories — 2.75%
- Pfizer Inc — 2.39%
- Danaher Corp — 2.09%
- Stryker Corp — 1.89%
- Medtronic PLC — 1.75%
- Elevance Health Inc — 1.46%
- Cigna Group/The — 1.27%
- Regeneron Pharmaceuticals Inc — 1.08%
- Cencora Inc — 0.96%
Only in PHSYX
- Novartis AG — 5.13%
- AstraZeneca plc — 4.67%
- Sanofi SA — 3.23%
- Edwards Lifesciences Corp. — 2.80%
- Roche Holding AG — 2.79%
- Novo Nordisk A/S — 1.90%
- Dexcom, Inc. — 1.64%
- Hoya Corp. — 1.52%
- Putnam Short Term Investment Fund — 1.35%
Asset mix
| Asset type | XLV | PHSYX |
|---|---|---|
| Stocks | 99.7% | 98.2% |
| Other | — | 1.4% |
| Cash & short-term funds | 0.3% | 0.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | XLV | PHSYX |
|---|---|---|
| US | 97.9% | 76.2% |
| CH | — | 7.9% |
| GB | — | 6.4% |
| FR | — | 3.2% |
| DK | — | 2.4% |
| JP | — | 2.4% |
| IE | 2.1% | — |
| NL | — | 1.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do XLV and PHSYX overlap?
What stocks do XLV and PHSYX have in common?
Should I own both XLV and PHSYX?
Which holds more stocks, XLV or PHSYX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.